Log In
Print this Print this

taspoglutide (ITM-077)

  Manage Alerts
Collapse Summary General Information
Company Ipsen Group
DescriptionLong acting analogue of GLP-1
Molecular Target Glucagon-like peptide-1 receptor (GLP-1R) (GLP1R)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation
PartnerChugai Pharmaceutical Co. Ltd.;
Teijin Pharma Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today